{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:05:13Z","timestamp":1793045113992,"version":"4.5.0"},"reference-count":342,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010376","name":"American Association of Clinical Endocrinologists","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010376","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.eprac.2021.04.008","type":"journal-article","created":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T03:46:10Z","timestamp":1623123970000},"page":"505-537","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":261,"title":["American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus"],"prefix":"10.1016","volume":"27","author":[{"given":"George","family":"Grunberger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Sherr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Allende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Blevins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Bode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda","family":"Handelsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Hellman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemarie","family":"Lajara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor Lawrence","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rodbard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Stec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Unger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.eprac.2021.04.008_bib1","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.4158\/EP171866.GL","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology Protocol for Standardized Production of Clinical Practice Guidelines, Algorithms, and Checklists - 2017 update","volume":"23","author":"Mechanick","year":"2017","journal-title":"Endocr Pract"},{"issue":"suppl 1","key":"10.1016\/j.eprac.2021.04.008_bib3","first-page":"S85","article-title":"7. Diabetes Technology: Standards of Medical Care in Diabetes-2021","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.eprac.2021.04.008_bib4","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.eprac.2021.04.008_bib5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.diabet.2017.10.009","article-title":"Practical implementation, education\u00a0and interpretation guidelines for continuous glucose monitoring: a French position statement","volume":"44","author":"Borot","year":"2018","journal-title":"Diabetes Metab J"},{"issue":"12","key":"10.1016\/j.eprac.2021.04.008_bib6","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.2337\/dc17-1600","article-title":"International consensus on use of continuous glucose monitoring","volume":"40","author":"Danne","year":"2017","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.eprac.2021.04.008_bib7","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.4158\/EP161392.CS","article-title":"Continuous glucose monitoring: a consensus conference of the American Association of Clinical Endocrinologists and American College of Endocrinology","volume":"22","author":"Fonseca","year":"2016","journal-title":"Endocr Pract"},{"issue":"11","key":"10.1016\/j.eprac.2021.04.008_bib8","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1210\/jc.2016-2534","article-title":"Technology-continuous subcutaneous insulin infusion therapy and continuous glucose monitoring in adults: an Endocrine Society Clinical Practice Guideline","volume":"101","author":"Peters","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.eprac.2021.04.008_bib9","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1093\/clinchem\/41.10.1522","article-title":"Composition of interstitial fluid","volume":"41","author":"Fogh-Andersen","year":"1995","journal-title":"Clin Chem"},{"issue":"8","key":"10.1016\/j.eprac.2021.04.008_bib10","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.2337\/dc17-1960","article-title":"Investigation of the accuracy of 18\u00a0marketed blood glucose monitors","volume":"41","author":"Klonoff","year":"2018","journal-title":"Diabetes Care"},{"issue":"10128","key":"10.1016\/j.eprac.2021.04.008_bib11","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0140-6736(18)30297-6","article-title":"Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial","volume":"391","author":"Heinemann","year":"2018","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.eprac.2021.04.008_bib12","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1089\/dia.2018.0252","article-title":"Switching from flash glucose monitoring to continuous glucose monitoring on hypoglycemia in adults with type 1 diabetes at high hypoglycemia risk: the extension phase of the I HART CGM study","volume":"20","author":"Reddy","year":"2018","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.eprac.2021.04.008_bib13","article-title":"Intermittent use of continuous glucose monitoring: expanding the clinical value of CGM","author":"Ziegler","year":"2020","journal-title":"J\u00a0Diabetes Sci Technol"},{"issue":"6","key":"10.1016\/j.eprac.2021.04.008_bib14","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.2337\/dc18-1631","article-title":"Nonadherence to insulin therapy detected by bluetooth-enabled pen cap is associated with poor glycemic control","volume":"42","author":"Munshi","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eprac.2021.04.008_bib15","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3389\/fendo.2017.00318","article-title":"Content analysis of mobile health applications on diabetes mellitus","volume":"8","author":"Izahar","year":"2017","journal-title":"Front Endocrinol"},{"issue":"6","key":"10.1016\/j.eprac.2021.04.008_bib17","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s10865-016-9765-3","article-title":"What do we know about mobile applications for diabetes self-management? A review of reviews","volume":"39","author":"Hood","year":"2016","journal-title":"J\u00a0Behav Med"},{"issue":"14","key":"10.1016\/j.eprac.2021.04.008_bib18","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Nathan","year":"1993","journal-title":"N\u00a0Engl J Med"},{"issue":"15","key":"10.1016\/j.eprac.2021.04.008_bib19","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"25","key":"10.1016\/j.eprac.2021.04.008_bib20","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1056\/NEJMoa052187","article-title":"Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes","volume":"353","author":"Nathan","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"9131","key":"10.1016\/j.eprac.2021.04.008_bib21","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","year":"1998","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.eprac.2021.04.008_bib22","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s13300-017-0280-5","article-title":"Glycated hemoglobin goals in the US remains unchanged through 2014","volume":"8","author":"Carls","year":"2017","journal-title":"Diabetes Ther"},{"issue":"1","key":"10.1016\/j.eprac.2021.04.008_bib23","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.19645","article-title":"Association of potentially modifiable diabetes care factors with glycemic control in patients with insulin-treated type 2 diabetes","volume":"3","author":"Lauffenburger","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.eprac.2021.04.008_bib24","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.2337\/dc12-1759","article-title":"Quality of care of people with type 2 diabetes in eight European countries: findings from the Guideline Adherence to Enhance Care (GUIDANCE) study","volume":"36","author":"Stone","year":"2013","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.eprac.2021.04.008_bib25","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.2337\/dci19-0017","article-title":"Understanding the economic costs of diabetes and prediabetes and what we may learn about reducing the health and economic burden of these conditions","volume":"42","author":"O\u2019Connell","year":"2019","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.eprac.2021.04.008_bib26","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1089\/dia.2018.0384","article-title":"State of type 1 diabetes management and outcomes from the T1D exchange in 2016-2018","volume":"21","author":"Foster","year":"2019","journal-title":"Diabetes Technol Ther"},{"issue":"8","key":"10.1016\/j.eprac.2021.04.008_bib27","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.2337\/dc19-0830","article-title":"Incidences of severe hypoglycemia and diabetic ketoacidosis and prevalence of microvascular complications stratified by age and glycemic control in US adult patients with type 1 diabetes: a real-world study","volume":"42","author":"Pettus","year":"2019","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.eprac.2021.04.008_bib28","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2337\/dc20-0171","article-title":"Acute hyperglycemia and spatial working memory in adolescents with type 1 diabetes","volume":"43","author":"\u0160uput Omladi\u010d","year":"2020","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.eprac.2021.04.008_bib29","article-title":"Longitudinal assessment of hippocampus structure in children with type 1 diabetes","volume":"19","author":"Foland-Ross","year":"2018","journal-title":"Pediatr Diabetes"},{"issue":"4","key":"10.1016\/j.eprac.2021.04.008_bib30","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2337\/dc20-2125","article-title":"Impact of type 1 diabetes in the developing brain in children: a longitudinal study","volume":"44","author":"Mauras","year":"2021","journal-title":"Diabetes Care"},{"issue":"suppl 1","key":"10.1016\/j.eprac.2021.04.008_bib31","first-page":"S73","article-title":"6. Glycemic Targets: Standards of Medical Care in Diabetes-2021","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.eprac.2021.04.008_bib32","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.diabet.2014.10.007","article-title":"Frequency and predictors of confirmed hypoglycaemia in type 1 and insulin-treated type 2 diabetes mellitus patients in a real-life setting: results from the DIALOG study","volume":"41","author":"Cariou","year":"2015","journal-title":"Diabetes Metab J"},{"issue":"5","key":"10.1016\/j.eprac.2021.04.008_bib33","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00592-015-0713-4","article-title":"Incidence and risk factors for severe and symptomatic hypoglycemia in type 1 diabetes. Results of the HYPOS-1 study","volume":"52","author":"Giorda","year":"2015","journal-title":"Acta Diabetol"},{"issue":"5","key":"10.1016\/j.eprac.2021.04.008_bib34","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/dom.12871","article-title":"Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: the EXAMINE trial","volume":"19","author":"Heller","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.eprac.2021.04.008_bib35","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s12020-018-1715-0","article-title":"Cause-specific risk of major adverse cardiovascular outcomes and hypoglycemic in patients with type 2 diabetes: a multicenter prospective cohort study","volume":"63","author":"Sun","year":"2019","journal-title":"Endocrine"},{"issue":"8","key":"10.1016\/j.eprac.2021.04.008_bib36","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.2337\/dc17-2677","article-title":"Hypoglycemia, cardiovascular outcomes, and death: the LEADER experience","volume":"41","author":"Zinman","year":"2018","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.eprac.2021.04.008_bib37","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1464-5491.2006.01880.x","article-title":"Frequency and risk factors of severe hypoglycaemia in insulin-treated type 2 diabetes: a cross-sectional survey","volume":"23","author":"Akram","year":"2006","journal-title":"Diabet Med"},{"issue":"12","key":"10.1016\/j.eprac.2021.04.008_bib38","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1046\/j.1464-5491.2003.01072.x","article-title":"Hypoglycaemia in insulin-treated type 2 diabetes: frequency, symptoms and impaired awareness","volume":"20","author":"Henderson","year":"2003","journal-title":"Diabet Med"},{"issue":"4","key":"10.1016\/j.eprac.2021.04.008_bib39","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1464-5491.2008.02413.x","article-title":"Prevalence of impaired awareness of hypoglycaemia in adults with type 1 diabetes","volume":"25","author":"Geddes","year":"2008","journal-title":"Diabet Med"},{"issue":"3","key":"10.1016\/j.eprac.2021.04.008_bib40","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/pedi.12077","article-title":"Prevalence of impaired awareness of hypoglycemia and identification of predictive symptoms in children and adolescents with type 1 diabetes","volume":"15","author":"Graveling","year":"2014","journal-title":"Pediatr Diabetes"},{"issue":"10","key":"10.1016\/j.eprac.2021.04.008_bib41","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1111\/dme.12496","article-title":"Hypoglycaemia symptoms and impaired awareness of hypoglycaemia in adults with type 1 diabetes: the association with diabetes duration","volume":"31","author":"Olsen","year":"2014","journal-title":"Diabet Med"},{"issue":"12","key":"10.1016\/j.eprac.2021.04.008_bib42","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1111\/j.1464-5491.2009.02834.x","article-title":"Prospective and retrospective recording of severe hypoglycaemia, and assessment of hypoglycaemia awareness in insulin-treated type 2 diabetes","volume":"26","author":"Akram","year":"2009","journal-title":"Diabet Med"},{"issue":"3","key":"10.1016\/j.eprac.2021.04.008_bib43","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1464-5491.1993.tb00050.x","article-title":"Frequency and symptoms of hypoglycaemia experienced by patients with type 2 diabetes treated with insulin","volume":"10","author":"Hepburn","year":"1993","journal-title":"Diabet Med"},{"issue":"1","key":"10.1016\/j.eprac.2021.04.008_bib44","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.diabres.2009.10.013","article-title":"Prevalence of impaired awareness of hypoglycaemia and frequency of hypoglycaemia in insulin-treated type 2 diabetes","volume":"87","author":"Schopman","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"10.1016\/j.eprac.2021.04.008_bib45","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-000935","article-title":"High prevalence of impaired awareness of hypoglycemia and severe hypoglycemia among people with insulin-treated type 2 diabetes: the Dutch Diabetes Pearl Cohort","volume":"8","author":"van Meijel","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"8918","key":"10.1016\/j.eprac.2021.04.008_bib46","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(94)91336-6","article-title":"Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes","volume":"344","author":"Cranston","year":"1994","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.eprac.2021.04.008_bib47","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.2337\/diab.42.11.1683","article-title":"Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM","volume":"42","author":"Fanelli","year":"1993","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.eprac.2021.04.008_bib48","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.2337\/diab.43.12.1426","article-title":"Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM","volume":"43","author":"Dagogo-Jack","year":"1994","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.eprac.2021.04.008_bib49","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.2337\/dc13-1004","article-title":"Restoration of self-awareness of hypoglycemia in adults with long-standing type 1 diabetes: hyperinsulinemic-hypoglycemic clamp substudy results from the HypoCOMPaSS trial","volume":"36","author":"Leelarathna","year":"2013","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.eprac.2021.04.008_bib50","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2337\/dc11-1855","article-title":"Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: post hoc epidemiologic analysis of the Accord trial","volume":"35","author":"Punthakee","year":"2012","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.eprac.2021.04.008_bib51","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2337\/dc15-1426","article-title":"Risk factors associated with severe hypoglycemia in older adults with type 1 diabetes","volume":"39","author":"Weinstock","year":"2016","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.eprac.2021.04.008_bib52","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.2337\/dc12-2480","article-title":"Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society","volume":"36","author":"Seaquist","year":"2013","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.eprac.2021.04.008_bib53","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1001\/jamainternmed.2014.1824","article-title":"National trends in US hospital admissions for hyperglycemia and hypoglycemia among Medicare beneficiaries, 1999 to 2011","volume":"174","author":"Lipska","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"7","key":"10.1016\/j.eprac.2021.04.008_bib54","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/pedi.12554","article-title":"ISPAD guidelines. Managing diabetes in preschool children","volume":"18","author":"Sundberg","year":"2017","journal-title":"Pediat Diabetes"},{"issue":"7","key":"10.1016\/j.eprac.2021.04.008_bib55","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.2337\/dc18-2625","article-title":"Young children have higher variability of insulin requirements: observations during hybrid closed-loop insulin delivery","volume":"42","author":"Dovc","year":"2019","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.eprac.2021.04.008_bib56","doi-asserted-by":"crossref","first-page":"464","DOI":"10.2337\/dc20-1060","article-title":"A\u00a0randomized clinical trial assessing continuous glucose monitoring (CGM) use with standardized education with or without a family behavioral intervention compared with fingerstick blood glucose monitoring in very young children with type 1 diabetes","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eprac.2021.04.008_bib57","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1471-2431-10-50","article-title":"Fear of hypoglycaemia in parents of young children with type 1 diabetes: a systematic review","volume":"10","author":"Barnard","year":"2010","journal-title":"BMC Pediatr"},{"issue":"1","key":"10.1016\/j.eprac.2021.04.008_bib58","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1464-5491.2009.02867.x","article-title":"Fear of hypoglycaemia in mothers and fathers of children with type 1 diabetes is associated with poor glycaemic control and parental emotional distress: a population-based study","volume":"27","author":"Haugstvedt","year":"2010","journal-title":"Diabet Med"},{"key":"10.1016\/j.eprac.2021.04.008_bib59","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.diabres.2017.05.004","article-title":"Impact of hypoglycaemia on patient-reported outcomes from a global, 24-country study of 27,585 people with type 1 and insulin-treated type 2 diabetes","volume":"130","author":"Khunti","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"10.1016\/j.eprac.2021.04.008_bib60","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2337\/dci18-0007","article-title":"Economic costs of diabetes in the US in 2017","volume":"41","year":"2018","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.eprac.2021.04.008_bib61","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00592-014-0598-7","article-title":"Impact of continuous glucose monitoring on quality of life, treatment satisfaction, and use of medical care resources: analyses from the SWITCH study","volume":"51","author":"Hommel","year":"2014","journal-title":"Acta Diabetol"},{"issue":"6","key":"10.1016\/j.eprac.2021.04.008_bib62","doi-asserted-by":"crossref","first-page":"971","DOI":"10.2337\/dc15-0078","article-title":"Current state of type 1 diabetes treatment in the US: updated data from the T1D exchange clinic registry","volume":"38","author":"Miller","year":"2015","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.eprac.2021.04.008_bib63","first-page":"751","article-title":"The psychosocial and financial impact of non-severe hypoglycemic events on people with diabetes: two international surveys","volume":"17","author":"Fulcher","year":"2014","journal-title":"J\u00a0Med Econ"},{"issue":"4","key":"10.1016\/j.eprac.2021.04.008_bib64","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/dme.12844","article-title":"Severe hypoglycaemia in adults with insulin-treated diabetes: impact on healthcare resources","volume":"33","author":"Heller","year":"2016","journal-title":"Diabet Med"},{"issue":"4","key":"10.1016\/j.eprac.2021.04.008_bib65","first-page":"905","article-title":"Potential cost implications of averting severe hypoglycemic events requiring hospitalization in high-risk adults with type 1 diabetes using real-time continuous glucose monitoring","volume":"10","author":"Bronstone","year":"2016","journal-title":"J\u00a0Ddiabetes Sci Technol"},{"issue":"4","key":"10.1016\/j.eprac.2021.04.008_bib66","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1177\/1932296816628547","article-title":"The cost-effectiveness of real-time continuous glucose monitoring (RT-CGM) in type 2 diabetes","volume":"10","author":"Fonda","year":"2016","journal-title":"J\u00a0Diabetes Sci Technol"},{"issue":"12","key":"10.1016\/j.eprac.2021.04.008_bib67","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1111\/dme.14046","article-title":"Modelling potential cost savings from use of real-time continuous glucose monitoring in pregnant women with type 1 diabetes","volume":"36","author":"Murphy","year":"2019","journal-title":"Diabet Med"},{"issue":"1","key":"10.1016\/j.eprac.2021.04.008_bib68","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2020-001330","article-title":"Cost analysis of the flash monitoring system (FreeStyle Libre 2) in adults with type 1 diabetes mellitus","volume":"8","author":"Oyag\u00fcez","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"6","key":"10.1016\/j.eprac.2021.04.008_bib69","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.2337\/dc17-1821","article-title":"Continuous glucose monitoring for adults with type 1 diabetes compared with self-monitoring of blood glucose: the DIAMOND randomized trial","volume":"41","author":"Wan","year":"2018","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.eprac.2021.04.008_bib70","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.2337\/dc19-2213","article-title":"Cost-effectiveness of Dexcom G6 real-time continuous glucose monitoring versus self-monitoring of blood glucose in patients with type 1 diabetes in the U.K","volume":"43","author":"Roze","year":"2020","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.eprac.2021.04.008_bib71","first-page":"353","article-title":"Comparative effectiveness and costs of insulin pump therapy for diabetes","volume":"23","author":"Ackermann","year":"2017","journal-title":"Am J Manag Care"},{"issue":"7","key":"10.1016\/j.eprac.2021.04.008_bib72","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.endinu.2018.03.008","article-title":"Cost-effectiveness analysis of sensor-augmented pump therapy with low glucose-suspend in patients with type 1 diabetes mellitus and high risk of hypoglycemia in Spain","volume":"65","author":"Conget","year":"2018","journal-title":"Endocrinol Diabetes Nutr"},{"issue":"20","key":"10.1016\/j.eprac.2021.04.008_bib73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta21200","article-title":"A\u00a0cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE Trial","volume":"21","author":"Heller","year":"2017","journal-title":"Health Technol Assess"},{"issue":"5","key":"10.1016\/j.eprac.2021.04.008_bib74","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s13300-017-0294-z","article-title":"Cost-effectiveness analysis of sensor-augmented insulin pump therapy with automated insulin suspension versus standard insulin pump therapy in patients with type 1 diabetes in Sweden","volume":"8","author":"Jendle","year":"2017","journal-title":"Diabetes Ther"},{"issue":"3","key":"10.1016\/j.eprac.2021.04.008_bib75","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1089\/dia.2018.0328","article-title":"Cost-effectiveness analysis of the MiniMed 670G hybrid closed-loop system versus continuous subcutaneous insulin infusion for treatment of type 1 diabetes","volume":"21","author":"Jendle","year":"2019","journal-title":"Diabetes Technol Ther"},{"issue":"5","key":"10.1016\/j.eprac.2021.04.008_bib76","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jval.2014.05.008","article-title":"A cost-effectiveness analysis of sensor-augmented insulin pump therapy and automated insulin suspension versus standard pump therapy for hypoglycemic unaware patients with type 1 diabetes","volume":"17","author":"Ly","year":"2014","journal-title":"Value Health"},{"issue":"7","key":"10.1016\/j.eprac.2021.04.008_bib77","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.numecd.2018.03.011","article-title":"Cost-effectiveness of sensor-augmented pump therapy in two different patient populations with type 1 diabetes in Italy","volume":"28","author":"Nicolucci","year":"2018","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"4","key":"10.1016\/j.eprac.2021.04.008_bib78","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016766","volume":"8","author":"Pollard","year":"2018","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.eprac.2021.04.008_bib79","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1089\/dia.2015.0224","article-title":"Cost-effectiveness of sensor-augmented pump therapy with low glucose suspend versus standard insulin pump therapy in two different patient populations with type 1 diabetes in France","volume":"18","author":"Roze","year":"2016","journal-title":"Diabetes Technol Ther"},{"issue":"3","key":"10.1016\/j.eprac.2021.04.008_bib80","first-page":"236","article-title":"Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a UK perspective","volume":"19","author":"Roze","year":"2016","journal-title":"J\u00a0Med Econ"},{"key":"10.1016\/j.eprac.2021.04.008_bib81","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2147\/CEOR.S186298","article-title":"Cost-effectiveness of sensor-augmented insulin pump therapy vs continuous subcutaneous insulin infusion in patients with type 1 diabetes in the Netherlands","volume":"11","author":"Roze","year":"2019","journal-title":"Clinicoecon Outcomes Res"},{"issue":"4","key":"10.1016\/j.eprac.2021.04.008_bib82","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2337\/dc18-1850","article-title":"Real-world costs of continuous insulin pump therapy and multiple daily injections for type 1 diabetes: a population-based and propensity-matched cohort from the Swedish National Diabetes Register","volume":"42","author":"Toresson Grip","year":"2019","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.eprac.2021.04.008_bib83","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/jama.2016.19975","article-title":"Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial","volume":"317","author":"Beck","year":"2017","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.eprac.2021.04.008_bib84","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2337\/dc19-1610","article-title":"Life and glucose control after 1 year of nationwide reimbursement of intermittently scanned continuous glucose monitoring in adults living with type 1 diabetes (FUTURE): a prospective observational real-world cohort study","volume":"43","author":"Charleer","year":"2020","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.eprac.2021.04.008_bib85","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.2337\/dc20-1531","article-title":"Impact of real-time continuous glucose monitoring in adults with type 1 diabetes on insulin pump therapy: results after the 24-month RESCUE study","volume":"43","author":"Charleer","year":"2020","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.eprac.2021.04.008_bib86","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2337\/dc11-1438","article-title":"Short- and long-term effects of real-time continuous glucose monitoring in patients with type 2 diabetes","volume":"35","author":"Vigersky","year":"2012","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.eprac.2021.04.008_bib87","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jdiacomp.2018.06.005","volume":"32","author":"Herman","year":"2018","journal-title":"J\u00a0Diabetes Complications"},{"issue":"6","key":"10.1016\/j.eprac.2021.04.008_bib88","doi-asserted-by":"crossref","first-page":"726","DOI":"10.4158\/EP151182.OR","article-title":"Clinical and cost-effectiveness of insulin delivery with V-go disposable insulin delivery device versus multiple daily injections in patients with type 2 diabetes inadequately controlled on basal insulin","volume":"22","author":"Lajara","year":"2016","journal-title":"Endocr Pract"},{"issue":"42","key":"10.1016\/j.eprac.2021.04.008_bib89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta22420","article-title":"Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT","volume":"22","author":"Blair","year":"2018","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.eprac.2021.04.008_bib90","doi-asserted-by":"crossref","first-page":"l1226","DOI":"10.1136\/bmj.l1226","article-title":"Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation","volume":"365","author":"Blair","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.eprac.2021.04.008_bib91","doi-asserted-by":"crossref","first-page":"h3234","DOI":"10.1136\/bmj.h3234","article-title":"Insulin pump therapy, multiple daily\u00a0injections, and cardiovascular mortality in 18,168 people with\u00a0type 1 diabetes: observational study","volume":"350","author":"Steineck","year":"2015","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.eprac.2021.04.008_bib93","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jval.2012.02.011","article-title":"Cost-effectiveness of sensor-augmented pump therapy in adults with type 1 diabetes in the United States","volume":"15","author":"Kamble","year":"2012","journal-title":"Value Health"},{"issue":"9","key":"10.1016\/j.eprac.2021.04.008_bib94","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.endonu.2016.05.011","article-title":"Clinical and economic benefits of integrated pump\/CGM technology therapy in patients with type 1 diabetes in Colombia","volume":"63","author":"Gomez","year":"2016","journal-title":"Endocrinol Nutr"},{"issue":"10","key":"10.1016\/j.eprac.2021.04.008_bib95","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1089\/dia.2019.0119","article-title":"A\u00a0review of predictive low glucose suspend and its effectiveness in preventing nocturnal hypoglycemia","volume":"21","author":"Chen","year":"2019","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"10.1016\/j.eprac.2021.04.008_bib96","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13643-020-01373-y","article-title":"Cost-effectiveness of health technologies in adults with type 1 diabetes: a systematic review and narrative synthesis","volume":"9","author":"Pease","year":"2020","journal-title":"Syst Rev"},{"issue":"suppl 1","key":"10.1016\/j.eprac.2021.04.008_bib97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP15672.GLSUPPL","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015","volume":"21","author":"Handelsman","year":"2015","journal-title":"Endocr Pract"},{"issue":"12","key":"10.1016\/j.eprac.2021.04.008_bib98","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.2337\/dc15-0187","article-title":"Clinical assessment of individualized glycemic goals in patients with type 2 diabetes: formulation of an algorithm based on a survey among leading worldwide diabetologists","volume":"38","author":"Cahn","year":"2015","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.eprac.2021.04.008_bib99","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/clinchem\/47.2.153","article-title":"Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin","volume":"47","author":"Bry","year":"2001","journal-title":"Clin Chem"},{"issue":"10","key":"10.1016\/j.eprac.2021.04.008_bib100","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1182\/blood-2008-04-154112","article-title":"Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c","volume":"112","author":"Cohen","year":"2008","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.eprac.2021.04.008_bib101","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1111\/dme.14065","article-title":"Associations between HbA1c and continuous glucose monitoring-derived glycaemic variables","volume":"36","author":"Hirsch","year":"2019","journal-title":"Diabet Med"},{"issue":"6","key":"10.1016\/j.eprac.2021.04.008_bib102","article-title":"The effect of anemia and the goal of optimal HbA1c control in diabetes and non-diabetes","volume":"12","author":"Katwal","year":"2020","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.eprac.2021.04.008_bib103","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.2337\/diacare.27.5.1200","article-title":"HbA1c levels are significantly lower in early and late pregnancy","volume":"27","author":"Nielsen","year":"2004","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.eprac.2021.04.008_bib104","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1089\/dia.2020.0387","article-title":"Robust determination of the optimal continuous glucose monitoring length of intervention to evaluate long-term glycemic control","volume":"23","author":"Herrero","year":"2020","journal-title":"Diabetes Technol Ther"},{"issue":"4","key":"10.1016\/j.eprac.2021.04.008_bib105","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1089\/dia.2017.0455","article-title":"Optimal sampling duration for continuous glucose monitoring to determine long-term glycemic control","volume":"20","author":"Riddlesworth","year":"2018","journal-title":"Diabetes Technol Ther"},{"issue":"3","key":"10.1016\/j.eprac.2021.04.008_bib106","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1089\/dia.2010.0156","article-title":"Optimal sampling intervals to assess long-term glycemic control using continuous glucose monitoring","volume":"13","author":"Xing","year":"2011","journal-title":"Diabetes Technol Ther"},{"issue":"11","key":"10.1016\/j.eprac.2021.04.008_bib107","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.2337\/dc18-1581","article-title":"Glucose management indicator (GMI): a new term for estimating A1C from continuous glucose monitoring","volume":"41","author":"Bergenstal","year":"2018","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.eprac.2021.04.008_bib108","first-page":"67","article-title":"Iron-deficiency anemia, non-iron-deficiency anemia and HbA1c among adults in the US","volume":"3","author":"Ford","year":"2011","journal-title":"J\u00a0Diabetes"},{"issue":"8","key":"10.1016\/j.eprac.2021.04.008_bib109","doi-asserted-by":"crossref","first-page":"994","DOI":"10.2337\/dc17-0636","article-title":"The fallacy of average: how using HbA1c alone to assess glycemic control can be misleading","volume":"40","author":"Beck","year":"2017","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.eprac.2021.04.008_bib110","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1089\/dia.2020.0501","article-title":"HbA1c and glucose management indicator discordance: a real-world analysis","volume":"23","author":"Perlman","year":"2020","journal-title":"Diabetes Technol Ther"},{"issue":"7","key":"10.1016\/j.eprac.2021.04.008_bib111","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1089\/dia.2020.0236","article-title":"Estimation of hemoglobin A1c from continuous glucose monitoring data in individuals with type 1 diabetes: is time in range all we need?","volume":"22","author":"Fabris","year":"2020","journal-title":"Diabetes Technol Ther"},{"issue":"5","key":"10.1016\/j.eprac.2021.04.008_bib112","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00592-011-0332-7","article-title":"Three-year comparison of subcutaneous insulin pump treatment with multi-daily injections on HbA1c, its variability and hospital burden of children with type 1 diabetes","volume":"49","author":"Fendler","year":"2012","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.eprac.2021.04.008_bib113","doi-asserted-by":"crossref","unstructured":"Xu Y, Grimsmann JM, Karges B, et\u00a0al. Personal glycation factors and calculated HbA1c for diabetes management: real-world data from the DPV registry. Diabetes Technol Ther. 2021. https:\/\/doi.org\/10.1089\/dia.2020.0553. Epub ahead of print [EL 2; ES].","DOI":"10.1089\/dia.2020.0553"},{"issue":"4","key":"10.1016\/j.eprac.2021.04.008_bib114","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1177\/1932296818822496","article-title":"The relationships between time in range, hyperglycemia metrics, and HbA1c","volume":"13","author":"Beck","year":"2019","journal-title":"J\u00a0Diabetes Sci Technol"},{"issue":"7","key":"10.1016\/j.eprac.2021.04.008_bib115","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1089\/dia.2019.0440","article-title":"Glucose time in range, time above range, and time below range depend on mean or median glucose or HbA1c, glucose coefficient of variation, and shape of the glucose distribution","volume":"22","author":"Rodbard","year":"2020","journal-title":"Diabetes Technol Ther"},{"issue":"2","key":"10.1016\/j.eprac.2021.04.008_bib116","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1089\/dia.2018.0310","article-title":"The relationship of hemoglobin A1C to time-in-range in patients with diabetes","volume":"21","author":"Vigersky","year":"2019","journal-title":"Diabetes Technol Ther"},{"issue":"11","key":"10.1016\/j.eprac.2021.04.008_bib117","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.2337\/dc18-1131","article-title":"Association of time in range, as assessed by continuous glucose monitoring, with diabetic retinopathy in type 2 diabetes","volume":"41","author":"Lu","year":"2018","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.eprac.2021.04.008_bib118","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-000991","article-title":"Glucose time in range and peripheral neuropathy in type 2 diabetes mellitus and chronic kidney disease","volume":"8","author":"Mayeda","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"10","key":"10.1016\/j.eprac.2021.04.008_bib119","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1089\/dia.2019.0499","article-title":"Association between continuous glucose monitoring-derived time in range, other core metrics, and albuminuria in type 2 diabetes","volume":"22","author":"Yoo","year":"2020","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.eprac.2021.04.008_bib120","first-page":"5817074","article-title":"Time in range, as a novel metric of glycemic control, is reversely associated with presence of diabetic cardiovascular autonomic neuropathy independent of HbA1c in Chinese type 2 diabetes","volume":"2020","author":"Guo","year":"2020","journal-title":"J\u00a0Diabetes Res"},{"key":"10.1016\/j.eprac.2021.04.008_bib121","doi-asserted-by":"crossref","unstructured":"Kim MY, Kim G, Park JY, et al. The association between continuous glucose monitoring-derived metrics and cardiovascular autonomic neuropathy in outpatients with type 2 diabetes. Diabetes Technol Ther. 2021a4. [EL 2; CSS]","DOI":"10.21203\/rs.3.rs-101449\/v1"},{"issue":"2","key":"10.1016\/j.eprac.2021.04.008_bib122","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1089\/dia.2019.0251","article-title":"Time in range is associated with carotid intima-media thickness in type 2 diabetes","volume":"22","author":"Lu","year":"2020","journal-title":"Diabetes Technol Ther"},{"issue":"2","key":"10.1016\/j.eprac.2021.04.008_bib123","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2337\/dc20-1862","article-title":"Time in range in relation to all-cause and cardiovascular mortality in patients with type 2 diabetes: a prospective cohort study","volume":"44","author":"Lu","year":"2021","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.eprac.2021.04.008_bib124","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1089\/dia.2010.0247","article-title":"Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups","volume":"13","author":"Hill","year":"2011","journal-title":"Diabetes Technol Ther"},{"issue":"3","key":"10.1016\/j.eprac.2021.04.008_bib125","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1089\/dia.2007.0293","article-title":"Characterizing glucose exposure for individuals with normal glucose tolerance using continuous glucose monitoring and ambulatory glucose profile analysis","volume":"10","author":"Mazze","year":"2008","journal-title":"Diabetes Technol Ther"},{"issue":"7","key":"10.1016\/j.eprac.2021.04.008_bib126","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s00125-019-4904-3","article-title":"Continuous glucose monitoring targets in type 1 diabetes pregnancy: every 5% time in range matters","volume":"62","author":"Murphy","year":"2019","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.eprac.2021.04.008_bib127","doi-asserted-by":"crossref","first-page":"400","DOI":"10.2337\/dc18-1444","article-title":"Validation of time in range as an outcome measure for diabetes clinical trials","volume":"42","author":"Beck","year":"2019","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.eprac.2021.04.008_bib128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/dia.2018.0362","article-title":"The association of biochemical hypoglycemia with the subsequent risk of a severe hypoglycemic event: analysis of the DCCT Data Set","volume":"21","author":"Beck","year":"2019","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"10.1016\/j.eprac.2021.04.008_bib129","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2337\/dc16-2215","article-title":"Glucose concentrations of less than 3.0 mmol\/L (54 mg\/dL) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"40","year":"2017","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.eprac.2021.04.008_bib130","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJMra1215228","article-title":"Mechanisms of hypoglycemia-associated autonomic failure in diabetes","volume":"369","author":"Cryer","year":"2013","journal-title":"New Eng J Med"},{"issue":"6","key":"10.1016\/j.eprac.2021.04.008_bib131","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1172\/JCI28735","article-title":"Mechanisms of sympathoadrenal failure and hypoglycemia in diabetes","volume":"116","author":"Cryer","year":"2006","journal-title":"J\u00a0Clin Invest"},{"issue":"suppl 27","key":"10.1016\/j.eprac.2021.04.008_bib132","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/pedi.12737","article-title":"ISPAD Clinical Practice Consensus Guidelines 2018: glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes","volume":"19","author":"DiMeglio","year":"2018","journal-title":"Pediatr Diabetes"},{"issue":"10110","key":"10.1016\/j.eprac.2021.04.008_bib133","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/S0140-6736(17)32400-5","article-title":"Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial","volume":"390","author":"Feig","year":"2017","journal-title":"Lancet"},{"issue":"suppl 1","key":"10.1016\/j.eprac.2021.04.008_bib134","first-page":"S200","article-title":"14. Management of diabetes in pregnancy: standards of medical care in diabetes-2021","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.eprac.2021.04.008_bib135","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/dme.13649","article-title":"Continuous glucose monitoring results in lower HbA1c in Malaysian women with insulin-treated gestational diabetes: a randomized controlled trial","volume":"35","author":"Paramasivam","year":"2018","journal-title":"Diabet Med"},{"key":"10.1016\/j.eprac.2021.04.008_bib136","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12902-015-0019-0","article-title":"Q-score: development of a new metric for continuous glucose monitoring that enables stratification of antihyperglycaemic therapies","volume":"15","author":"Augstein","year":"2015","journal-title":"BMC Endocr Disord"},{"issue":"5","key":"10.1016\/j.eprac.2021.04.008_bib137","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1089\/dia.2017.0388","article-title":"Beyond HbA1c: comparing glycemic variability and glycemic indices in predicting hypoglycemia in type\u00a01\u00a0and type 2 diabetes","volume":"20","author":"Rama Chandran","year":"2018","journal-title":"Diabetes Technol Ther"},{"issue":"2","key":"10.1016\/j.eprac.2021.04.008_bib138","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1089\/dia.2017.0306","article-title":"Relation between hypoglycemia and glycemic variability in type 2 diabetes patients with insulin therapy: a study based on continuous glucose monitoring","volume":"20","author":"Uemura","year":"2018","journal-title":"Diabetes Technol Ther"},{"issue":"2","key":"10.1016\/j.eprac.2021.04.008_bib139","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2020-001753","article-title":"Long-term variability of glycemic markers and risk of all-cause mortality in type 2 diabetes: the Look AHEAD study","volume":"8","author":"Kaze","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"2","key":"10.1016\/j.eprac.2021.04.008_bib140","doi-asserted-by":"crossref","first-page":"R86","DOI":"10.1186\/cc13851","article-title":"Coefficient of glucose variation is independently associated with mortality in critically ill patients receiving intravenous insulin","volume":"18","author":"Lanspa","year":"2014","journal-title":"Crit Care"},{"issue":"7","key":"10.1016\/j.eprac.2021.04.008_bib141","doi-asserted-by":"crossref","first-page":"832","DOI":"10.2337\/dc16-1769","article-title":"Toward defining the threshold between low and high glucose variability in diabetes","volume":"40","author":"Monnier","year":"2017","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.eprac.2021.04.008_bib142","doi-asserted-by":"crossref","first-page":"821","DOI":"10.2337\/dc19-1549","article-title":"Respective contributions of glycemic variability and mean daily glucose as predictors of hypoglycemia in type 1 diabetes: are they equivalent?","volume":"43","author":"Monnier","year":"2020","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.eprac.2021.04.008_bib143","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1089\/dia.2012.0062","article-title":"Hypo- and hyperglycemia in relation to the mean, standard deviation, coefficient of variation, and nature of the glucose distribution","volume":"14","author":"Rodbard","year":"2012","journal-title":"Diabetes Technol Ther"},{"issue":"8","key":"10.1016\/j.eprac.2021.04.008_bib144","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1089\/dia.2011.0049","article-title":"The contribution of glucose variability to asymptomatic hypoglycemia in persons with type 2 diabetes","volume":"13","author":"Monnier","year":"2011","journal-title":"Diabetes Technol Ther"},{"issue":"4","key":"10.1016\/j.eprac.2021.04.008_bib145","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2337\/dc15-2035","article-title":"Glucose variability: timing, risk analysis, and relationship to hypoglycemia in diabetes","volume":"39","author":"Kovatchev","year":"2016","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.eprac.2021.04.008_bib146","doi-asserted-by":"crossref","first-page":"538","DOI":"10.2337\/dc16-2482","article-title":"REPLACE-BG: a randomized trial comparing continuous glucose monitoring with and without routine blood glucose monitoring in adults with well-controlled type 1 diabetes","volume":"40","author":"Aleppo","year":"2017","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.eprac.2021.04.008_bib147","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/cen.13290","article-title":"Real-time continuous glucose monitoring in type 1 diabetes: a systematic review and individual patient data meta-analysis","volume":"86","author":"Benkhadra","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10057","key":"10.1016\/j.eprac.2021.04.008_bib148","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1016\/S0140-6736(16)31535-5","article-title":"Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial","volume":"388","author":"Bolinder","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.eprac.2021.04.008_bib149","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s13300-016-0223-6","article-title":"Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter, open-label randomized controlled trial","volume":"8","author":"Haak","year":"2017","journal-title":"Diabetes Ther"},{"issue":"3","key":"10.1016\/j.eprac.2021.04.008_bib150","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s13300-017-0255-6","article-title":"Use of flash glucose-sensing technology for 12 months as a replacement for blood glucose monitoring in insulin-treated type 2 diabetes","volume":"8","author":"Haak","year":"2017","journal-title":"Diabetes Ther"},{"issue":"4","key":"10.1016\/j.eprac.2021.04.008_bib151","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/jama.2016.19976","article-title":"Continuous glucose monitoring vs conventional therapy for glycemic control in adults with type 1 diabetes treated with multiple daily insulin injections: the GOLD randomized clinical trial","volume":"317","author":"Lind","year":"2017","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.eprac.2021.04.008_bib152","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00125-017-4527-5","article-title":"Impact of flash glucose monitoring on hypoglycaemia in adults with type 1 diabetes managed with multiple daily injection therapy: a pre-specified subgroup analysis of the IMPACT randomised controlled trial","volume":"61","author":"Oskarsson","year":"2018","journal-title":"Diabetologia"},{"issue":"9","key":"10.1016\/j.eprac.2021.04.008_bib153","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1089\/dia.2016.0171","article-title":"Comparison of different treatment modalities for type 1 diabetes, including sensor-augmented insulin regimens, in 52 weeks of follow-up: a COMISAIR study","volume":"18","author":"\u0160oupal","year":"2016","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"10.1016\/j.eprac.2021.04.008_bib154","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2337\/dc19-0888","article-title":"Glycemic outcomes in adults with T1D are impacted more by continuous glucose monitoring than by insulin delivery method: 3 years of follow-up from the COMISAIR study","volume":"43","author":"\u0160oupal","year":"2020","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.eprac.2021.04.008_bib155","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S2213-8587(16)30193-0","article-title":"Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial","volume":"4","author":"van Beers","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"10.1016\/j.eprac.2021.04.008_bib156","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1210\/jc.2017-02498","article-title":"Effect of continuous glucose monitoring on glycemic control, acute admissions, and quality of life: a real-world study","volume":"103","author":"Charleer","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.eprac.2021.04.008_bib157","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-000809","article-title":"Improved well-being and decreased disease burden after 1-year use of flash glucose monitoring (FLARE-NL4)","volume":"7","author":"Fokkert","year":"2019","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"6","key":"10.1016\/j.eprac.2021.04.008_bib158","doi-asserted-by":"crossref","first-page":"736","DOI":"10.2337\/dc17-0133","article-title":"The impact of continuous glucose monitoring on markers of quality of life in adults with type 1 diabetes: further findings from the DIAMOND randomized clinical trial","volume":"40","author":"Polonsky","year":"2017","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.eprac.2021.04.008_bib159","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.2337\/dc18-0166","article-title":"Effect of flash glucose monitoring technology on glycemic control and treatment satisfaction in patients with type 2 diabetes","volume":"42","author":"Yaron","year":"2019","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.eprac.2021.04.008_bib160","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.diabres.2012.03.002","article-title":"Results that matter: structured vs. unstructured self-monitoring of blood glucose in type 2 diabetes","volume":"97","author":"Parkin","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"10.1016\/j.eprac.2021.04.008_bib161","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2337\/dc13-2112","article-title":"The diabetes control and complications trial\/epidemiology of diabetes interventions and complications study at 30 years: overview","volume":"37","author":"Nathan","year":"2014","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.eprac.2021.04.008_bib162","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1089\/dia.2015.0358","article-title":"The burden of structured self-monitoring of blood glucose on diabetes-specific quality of life and locus of control in patients with noninsulin-treated type 2 diabetes: the PRISMA study","volume":"18","author":"Russo","year":"2016","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"10.1016\/j.eprac.2021.04.008_bib163","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3067","article-title":"Contribution of structured self-monitoring of blood glucose to self-efficacy in poorly controlled diabetes patients in China","volume":"35","author":"Shen","year":"2019","journal-title":"Diabetes Metab Res Rev"},{"issue":"5","key":"10.1016\/j.eprac.2021.04.008_bib164","doi-asserted-by":"crossref","first-page":"903","DOI":"10.2337\/dc18-1854","article-title":"Self-monitoring of blood glucose in youth-onset type 2 diabetes: results from the TODAY study","volume":"42","author":"Weinstock","year":"2019","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.eprac.2021.04.008_bib165","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1089\/dia.2017.0363","volume":"20","author":"\u00d3lafsd\u00f3ttir","year":"2018","journal-title":"Diabetes Technol Ther"},{"issue":"23","key":"10.1016\/j.eprac.2021.04.008_bib166","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1001\/jama.2020.6928","article-title":"Effect of continuous glucose monitoring on hypoglycemia in older adults with type 1 diabetes: a randomized clinical trial","volume":"323","author":"Pratley","year":"2020","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.eprac.2021.04.008_bib167","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1007\/s00125-012-2708-9","article-title":"The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial","volume":"55","author":"Battelino","year":"2012","journal-title":"Diabetologia"},{"issue":"23","key":"10.1016\/j.eprac.2021.04.008_bib168","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1001\/jama.2020.6940","article-title":"Effect of continuous glucose monitoring on glycemic control in adolescents and young adults with type 1 diabetes: a randomized clinical trial","volume":"323","author":"Laffel","year":"2020","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.eprac.2021.04.008_bib169","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2337\/dc11-1746","article-title":"A\u00a0randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to <10 years","volume":"35","author":"Mauras","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eprac.2021.04.008_bib170","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1089\/dia.2018.0339","article-title":"Flash glucose monitoring accepted in daily life of children and adolescents with type 1 diabetes and reduction of severe hypoglycemia in real-life use","volume":"21","author":"Messaaoui","year":"2019","journal-title":"Diabetes Technol Ther"},{"issue":"5","key":"10.1016\/j.eprac.2021.04.008_bib171","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1016\/j.dsx.2019.07.054","article-title":"Freestyle libre flash glucose monitoring improves patient quality of life measures in children with type 1 diabetes mellitus (T1DM) with appropriate provision of education and support by healthcare professionals","volume":"13","author":"Pintus","year":"2019","journal-title":"Diabetes Metab Syndr"},{"issue":"7","key":"10.1016\/j.eprac.2021.04.008_bib172","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/pedi.12729","article-title":"Non-adjunctive flash glucose monitoring system use during summer-camp in children with type 1 diabetes: the free-summer study","volume":"19","author":"Piona","year":"2018","journal-title":"Pediatr Diabetes"},{"issue":"10","key":"10.1016\/j.eprac.2021.04.008_bib173","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.2337\/dc20-0736","article-title":"Use of factory-calibrated real-time continuous glucose monitoring improves time in target and HbA1c in a multiethnic cohort of adolescents and young adults with type 1 diabetes: the MILLENNIALS study","volume":"43","author":"Thabit","year":"2020","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.eprac.2021.04.008_bib174","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.2337\/dc18-0938","article-title":"The use of continuous glucose monitoring with remote monitoring improves psychosocial measures in parents of children with type 1 diabetes: a randomized crossover trial","volume":"41","author":"Burckhardt","year":"2018","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.eprac.2021.04.008_bib175","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/dia.2018.0292","article-title":"Use of continuous glucose monitoring trends to facilitate exercise in children with type 1 diabetes","volume":"21","author":"Burckhardt","year":"2019","journal-title":"Diabetes Technol Ther"},{"issue":"4","key":"10.1016\/j.eprac.2021.04.008_bib176","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/s13300-019-0616-4","article-title":"The potential impact of the FreeStyle Libre flash glucose monitoring system on mental well-being and treatment satisfaction in patients with type 1 diabetes: a prospective study","volume":"10","author":"Al Hayek","year":"2019","journal-title":"Diabetes Ther"},{"issue":"4","key":"10.1016\/j.eprac.2021.04.008_bib177","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s13300-020-00793-2","article-title":"Effectiveness of the freestyle libre flash glucose monitoring system on diabetes distress among individuals with type 1 diabetes: a prospective study","volume":"11","author":"Al Hayek","year":"2020","journal-title":"Diabetes Ther"},{"issue":"8","key":"10.1016\/j.eprac.2021.04.008_bib178","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1111\/dme.13988","article-title":"Maternal glycaemic control and risk of neonatal hypoglycaemia in type 1 diabetes pregnancy: a secondary analysis of the CONCEPTT trial","volume":"36","author":"Yamamoto","year":"2019","journal-title":"Diabet Med"},{"issue":"8","key":"10.1016\/j.eprac.2021.04.008_bib179","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1111\/dom.13310","article-title":"Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): a multicentre randomized controlled trial","volume":"20","author":"Voormolen","year":"2018","journal-title":"Diabetes Obes Metab"},{"issue":"12","key":"10.1016\/j.eprac.2021.04.008_bib180","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1089\/dia.2020.0085","article-title":"Performance of the Dexcom G6 continuous glucose monitoring system in pregnant women with diabetes","volume":"22","author":"Castorino","year":"2020","journal-title":"Diabetes Technol Ther"},{"issue":"12","key":"10.1016\/j.eprac.2021.04.008_bib181","doi-asserted-by":"crossref","first-page":"4674","DOI":"10.1210\/jc.2013-4332","article-title":"Continuous glucose monitoring effects on maternal glycemic control and pregnancy outcomes in patients with gestational diabetes mellitus: a prospective cohort study","volume":"99","author":"Yu","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2021.04.008_bib182","doi-asserted-by":"crossref","first-page":"19920","DOI":"10.1038\/srep19920","article-title":"Effect of a CGMS and SMBG on maternal and neonatal outcomes in gestational diabetes mellitus: a randomized controlled trial","volume":"6","author":"Wei","year":"2016","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.eprac.2021.04.008_bib183","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1055\/s-0039-1678733","article-title":"Real-time continuous glucose monitoring in gestational diabetes: a randomized controlled trial","volume":"36","author":"Lane","year":"2019","journal-title":"Am J Perinatol"},{"issue":"2","key":"10.1016\/j.eprac.2021.04.008_bib184","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1089\/dia.2020.0396","article-title":"Remote application and use of real-time continuous glucose monitoring by adults with type 2 diabetes in a virtual diabetes clinic","volume":"23","author":"Bergenstal","year":"2021","journal-title":"Diabetes Technol Ther"},{"issue":"3","key":"10.1016\/j.eprac.2021.04.008_bib185","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/1479164115624680","article-title":"Sensor and software use for the glycaemic management of insulin-treated type 1 and type 2 diabetes patients","volume":"13","author":"Ajjan","year":"2016","journal-title":"Diabetes Vasc Dis Res"},{"issue":"4","key":"10.1016\/j.eprac.2021.04.008_bib186","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1177\/1932296818813581","article-title":"Continuous glucose monitoring integration in clinical practice: a stepped guide to data review and interpretation","volume":"13","author":"Aleppo","year":"2019","journal-title":"J\u00a0Diabetes Sci Technol"},{"key":"10.1016\/j.eprac.2021.04.008_bib187","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/dme.13944","article-title":"Beyond HbA1c: using continuous glucose monitoring metrics to enhance interpretation of treatment effect and improve clinical decision-making","volume":"36","author":"Brown","year":"2019","journal-title":"Diabet Med"},{"key":"10.1016\/j.eprac.2021.04.008_bib188","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ecl.2019.10.010","article-title":"HbA(1c): the glucose management indicator, time in range, and standardization of continuous glucose monitoring reports in clinical practice","volume":"49","author":"Carlson","year":"2020","journal-title":"Endocrinol Metabol Clin North Am"},{"issue":"4","key":"10.1016\/j.eprac.2021.04.008_bib189","doi-asserted-by":"crossref","first-page":"306","DOI":"10.4158\/EP-2018-0177","article-title":"Evaluation of insulin glargine and exenatide alone and in combination: a randomized clinical trial with continuous glucose monitoring and ambulatory glucose profile analysis","volume":"25","author":"Carlson","year":"2019","journal-title":"Endocr Pract"},{"issue":"4","key":"10.1016\/j.eprac.2021.04.008_bib190","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1177\/1932296819851790","article-title":"A review of continuous glucose monitoring data interpretation in the age of automated insulin delivery","volume":"13","author":"Ekhlaspour","year":"2019","journal-title":"J\u00a0Diabetes Sci Technol"},{"issue":"suppl 2","key":"10.1016\/j.eprac.2021.04.008_bib191","doi-asserted-by":"crossref","first-page":"S217","DOI":"10.1089\/dia.2019.0034","article-title":"Utilizing the ambulatory glucose profile to standardize and implement continuous glucose monitoring in clinical practice","volume":"21","author":"Johnson","year":"2019","journal-title":"Diabetes Technol Ther"},{"issue":"5","key":"10.1016\/j.eprac.2021.04.008_bib192","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1089\/dia.2020.0524","article-title":"The ambulatory glucose profile: opportunities for enhancement","volume":"23","author":"Rodbard","year":"2021","journal-title":"Diabetes Technol Ther"},{"issue":"11","key":"10.1016\/j.eprac.2021.04.008_bib193","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.2337\/dc20-0112","article-title":"Real-time CGM Is superior to flash glucose monitoring for glucose control in type 1 diabetes: the CORRIDA randomized controlled trial","volume":"43","author":"H\u00e1skov\u00e1","year":"2020","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.eprac.2021.04.008_bib194","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.2337\/dc18-1150","article-title":"Clinical implications of real-time and intermittently scanned continuous glucose monitoring","volume":"41","author":"Edelman","year":"2018","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.eprac.2021.04.008_bib195","first-page":"24","article-title":"Selecting the appropriate continuous glucose monitoring system - a practical approach","volume":"14","author":"Adolfsson","year":"2018","journal-title":"Eur Endocrinol"},{"issue":"2","key":"10.1016\/j.eprac.2021.04.008_bib196","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.diabres.2014.08.011","article-title":"An exploratory trial of basal and prandial insulin initiation and titration for type 2 diabetes in primary care with adjunct retrospective continuous glucose monitoring: INITIATION study","volume":"106","author":"Blackberry","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"10.1016\/j.eprac.2021.04.008_bib197","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1177\/1932296815581052","article-title":"Hypoglycemia in type 2 diabetes--more common than you think: a continuous glucose monitoring study","volume":"9","author":"Gehlaut","year":"2015","journal-title":"J\u00a0Diabetes Sci Technol"},{"issue":"8","key":"10.1016\/j.eprac.2021.04.008_bib198","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1007\/s12325-017-0576-x","article-title":"Assessing the therapeutic utility of professional continuous glucose monitoring in type 2 diabetes across various therapies: a retrospective evaluation","volume":"34","author":"Kesavadev","year":"2017","journal-title":"Adv Ther"},{"issue":"6","key":"10.1016\/j.eprac.2021.04.008_bib199","doi-asserted-by":"crossref","first-page":"449","DOI":"10.4093\/dmj.2014.38.6.449","article-title":"Effectiveness of 3-day continuous glucose monitoring for improving glucose control in type 2 diabetic patients in clinical practice","volume":"38","author":"Kim","year":"2014","journal-title":"Diabetes Metab J"},{"issue":"9","key":"10.1016\/j.eprac.2021.04.008_bib200","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1089\/dia.2013.0027","article-title":"Benefits of short-term professional continuous glucose monitoring in clinical practice","volume":"15","author":"Leinung","year":"2013","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"10.1016\/j.eprac.2021.04.008_bib201","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2213-8587(19)30385-7","article-title":"Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trial","volume":"8","author":"Furler","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.1016\/j.eprac.2021.04.008_bib202","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1038\/s41598-019-42555-6","article-title":"Clinical efficacy of professional continuous glucose monitoring in improving glycemic control among children with type 1 diabetes mellitus: an open-label randomized control trial","volume":"9","author":"Raviteja","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.eprac.2021.04.008_bib203","article-title":"Digital diabetes management: a literature review of smart insulin pens","author":"Heinemann","year":"2021","journal-title":"J\u00a0Diabetes Sci Technol"},{"issue":"9","key":"10.1016\/j.eprac.2021.04.008_bib204","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S2213-8587(17)30217-6","article-title":"Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial","volume":"5","author":"Beck","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"10.1016\/j.eprac.2021.04.008_bib205","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.2337\/dc14-0030","article-title":"Recovery of hypoglycemia awareness in long-standing type 1 diabetes: a multicenter 2\u00a0\u00d7 2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose self-monitoring (HypoCOMPaSS)","volume":"37","author":"Little","year":"2014","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.eprac.2021.04.008_bib206","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/dia.2017.0283","article-title":"Complex assessment of metabolic effectiveness of insulin pump therapy in patients with type 2 diabetes beyond HbA1c reduction","volume":"20","author":"Chlup","year":"2018","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"10.1016\/j.eprac.2021.04.008_bib207","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1089\/dia.2015.0159","article-title":"The impact of insulin pump therapy on glycemic profiles in patients with type 2 diabetes: data from the OpT2mise study","volume":"18","author":"Conget","year":"2016","journal-title":"Diabetes Technol Ther"},{"issue":"9950","key":"10.1016\/j.eprac.2021.04.008_bib208","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/S0140-6736(14)61037-0","article-title":"Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial","volume":"384","author":"Reznik","year":"2014","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.eprac.2021.04.008_bib209","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/dom.12642","article-title":"Sustained efficacy of insulin pump therapy compared with multiple daily injections in type 2 diabetes: 12-month data from the OpT2mise randomized trial","volume":"18","author":"Aronson","year":"2016","journal-title":"Diabetes Obes Metab"},{"issue":"5","key":"10.1016\/j.eprac.2021.04.008_bib210","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1089\/dia.2011.0228","article-title":"Patient perceptions of using the OmniPod system compared with conventional insulin pumps in young adults with type 1 diabetes","volume":"14","author":"Lebenthal","year":"2012","journal-title":"Diabetes Technol Ther"},{"issue":"8","key":"10.1016\/j.eprac.2021.04.008_bib211","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/pedi.12754","article-title":"Real-world outcomes of insulin pump compared to injection therapy in a population-based sample of children with type 1 diabetes","volume":"19","author":"Burckhardt","year":"2018","journal-title":"Pediatr Diabetes"},{"issue":"2","key":"10.1016\/j.eprac.2021.04.008_bib212","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00592-013-0481-y","article-title":"A\u00a07-year follow-up retrospective, international, multicenter study of insulin pump therapy in children and adolescents with type 1 diabetes","volume":"51","author":"Mameli","year":"2014","journal-title":"Acta Diabetol"},{"issue":"8","key":"10.1016\/j.eprac.2021.04.008_bib213","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/pedi.12121","article-title":"Insulin pump use in young children in the T1D exchange clinic registry is associated with lower hemoglobin A1c levels than injection therapy","volume":"15","author":"Blackman","year":"2014","journal-title":"Pediatr Diabetes"},{"issue":"1","key":"10.1016\/j.eprac.2021.04.008_bib214","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00125-015-3790-6","article-title":"Use of insulin pump therapy in children and adolescents with type 1 diabetes and its impact on metabolic control: comparison of results from three large, transatlantic paediatric registries","volume":"59","author":"Sherr","year":"2016","journal-title":"Diabetologia"},{"issue":"12","key":"10.1016\/j.eprac.2021.04.008_bib215","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.2337\/dc18-1437","article-title":"Pumps or multiple daily injections in pregnancy involving type 1 diabetes: a prespecified analysis of the CONCEPTT randomized trial","volume":"41","author":"Feig","year":"2018","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.eprac.2021.04.008_bib216","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/dme.13106","article-title":"Insulin pump use compared with intravenous insulin during labour and delivery: the INSPIRED observational cohort study","volume":"33","author":"Drever","year":"2016","journal-title":"Diabet Med"},{"issue":"11","key":"10.1016\/j.eprac.2021.04.008_bib217","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1089\/dia.2016.0166","article-title":"Clinical outcomes after 1 year of augmented insulin pump therapy in patients with diabetes in a specialized diabetes center in Medell\u00edn, Colombia","volume":"18","author":"Ramirez-Rincon","year":"2016","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.eprac.2021.04.008_bib218","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1399-5448.2011.00793.x","article-title":"Effectiveness of sensor-augmented pump therapy in children and adolescents with type 1 diabetes in the STAR 3 study","volume":"13","author":"Slover","year":"2012","journal-title":"Pediatr Diabetes"},{"issue":"2","key":"10.1016\/j.eprac.2021.04.008_bib219","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/dia.2011.0162","article-title":"STAR 3 Study Group. Health-related quality of life and treatment satisfaction in the Sensor-Augmented Pump Therapy for A1C Reduction 3 (STAR 3) trial","volume":"14","author":"Rubin","year":"2012","journal-title":"Diabetes Technol Ther"},{"issue":"4","key":"10.1016\/j.eprac.2021.04.008_bib220","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.diabet.2016.12.009","article-title":"Multicentre randomized controlled trial with sensor-augmented pump vs multiple daily injections in hospitalized patients with type 2 diabetes in China: Time to reach target glucose","volume":"43","author":"Gu","year":"2017","journal-title":"Diabetes Metab"},{"issue":"12","key":"10.1016\/j.eprac.2021.04.008_bib221","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1089\/dia.2013.0078","article-title":"Hypoglycemia and blood glucose fluctuations in the application of a sensor-augmented insulin pump","volume":"15","author":"Luo","year":"2013","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.eprac.2021.04.008_bib222","article-title":"Type 1 diabetes management with technology: patterns of utilization and effects on glucose control using real-world evidence","volume":"cd200098","author":"Sun","year":"2021","journal-title":"Clin Diabetes"},{"issue":"3","key":"10.1016\/j.eprac.2021.04.008_bib223","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1056\/NEJMoa1303576","article-title":"Threshold-based insulin-pump interruption for reduction of hypoglycemia","volume":"369","author":"Bergenstal","year":"2013","journal-title":"New Eng J Med"},{"issue":"12","key":"10.1016\/j.eprac.2021.04.008_bib224","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1001\/jama.2013.277818","article-title":"Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial","volume":"310","author":"Ly","year":"2013","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.eprac.2021.04.008_bib225","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1089\/dia.2016.0319","article-title":"Evaluation of a predictive low-glucose management system in-clinic","volume":"19","author":"Buckingham","year":"2017","journal-title":"Diabetes Technol Ther"},{"issue":"10","key":"10.1016\/j.eprac.2021.04.008_bib226","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.2337\/dc18-0771","article-title":"Predictive low-glucose suspend reduces hypoglycemia in adults, adolescents, and children with type 1 diabetes in an at-home randomized crossover study: results of the PROLOG trial","volume":"41","author":"Forlenza","year":"2018","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.eprac.2021.04.008_bib227","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1089\/dia.2016.0349","article-title":"\"Let the algorithm do the Work\": reduction of hypoglycemia using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in pediatric type 1 diabetes patients","volume":"19","author":"Biester","year":"2017","journal-title":"Diabetes Technol Ther"},{"issue":"18","key":"10.1016\/j.eprac.2021.04.008_bib228","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1056\/NEJMoa1907863","article-title":"Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes","volume":"381","author":"Brown","year":"2019","journal-title":"New Eng J Med"},{"issue":"5","key":"10.1016\/j.eprac.2021.04.008_bib229","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1089\/dia.2013.0002","article-title":"The effects of inpatient hybrid closed-loop therapy initiated within 1 week of type 1 diabetes diagnosis","volume":"15","author":"Buckingham","year":"2013","journal-title":"Diabetes Technol Ther"},{"issue":"4","key":"10.1016\/j.eprac.2021.04.008_bib230","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1089\/dia.2019.0302","article-title":"Switching from suspend-before-low insulin pump technology to a hybrid closed-loop system improves glucose control and reduces glucose variability: a retrospective observational case-control study","volume":"22","author":"Lepore","year":"2020","journal-title":"Diabetes Technol Ther"},{"issue":"5","key":"10.1016\/j.eprac.2021.04.008_bib231","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1089\/dia.2019.0417","article-title":"The efficacy of technology in type 1 diabetes: a systematic review, network meta-analysis, and narrative synthesis","volume":"22","author":"Pease","year":"2020","journal-title":"Diabetes Technol Ther"},{"issue":"12","key":"10.1016\/j.eprac.2021.04.008_bib232","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1089\/dia.2016.0288","article-title":"Glycemia, treatment satisfaction, cognition, and sleep quality in adults and adolescents with type 1 diabetes when using a closed-loop system overnight versus sensor-augmented pump with low-glucose suspend function: a randomized crossover study","volume":"18","author":"Sharifi","year":"2016","journal-title":"Diabetes Technol Ther"},{"issue":"10155","key":"10.1016\/j.eprac.2021.04.008_bib233","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0140-6736(18)31947-0","article-title":"Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial","volume":"392","author":"Tauschmann","year":"2018","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.eprac.2021.04.008_bib234","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S2213-8587(17)30167-5","article-title":"Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials","volume":"5","author":"Weisman","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.1016\/j.eprac.2021.04.008_bib235","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/dom.13482","article-title":"Closed-loop\u00a0driven by control-to-range algorithm outperforms threshold-low-glucose-suspend insulin delivery on glucose control albeit not on nocturnal hypoglycaemia in prepubertal patients with type 1 diabetes in a supervised hotel setting","volume":"21","author":"Renard","year":"2019","journal-title":"Diabetes Obes Metab"},{"issue":"9","key":"10.1016\/j.eprac.2021.04.008_bib236","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJMoa2004736","article-title":"A\u00a0randomized trial of closed-loop\u00a0control in children with type 1 diabetes","volume":"383","author":"Breton","year":"2020","journal-title":"New Eng J Med"},{"key":"10.1016\/j.eprac.2021.04.008_bib237","doi-asserted-by":"crossref","first-page":"k1310","DOI":"10.1136\/bmj.k1310","article-title":"Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis","volume":"361","author":"Bekiari","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.eprac.2021.04.008_bib238","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.metabol.2018.10.002","article-title":"Effectiveness of artificial pancreas in the non-adult population: a systematic review and network meta-analysis","volume":"90","author":"Karageorgiou","year":"2019","journal-title":"Metab Clin Exp"},{"issue":"4","key":"10.1016\/j.eprac.2021.04.008_bib239","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2337\/dc20-2250","article-title":"Improved glycemic outcomes with Medtronic MiniMed advanced hybrid closed-loop delivery: results from a randomized crossover trial comparing automated insulin delivery with predictive low glucose suspend in people with type 1 diabetes","volume":"44","author":"Collyns","year":"2021","journal-title":"Diabetes Care"},{"issue":"10270","key":"10.1016\/j.eprac.2021.04.008_bib240","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0140-6736(20)32514-9","article-title":"A\u00a0comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial","volume":"397","author":"Bergenstal","year":"2021","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.eprac.2021.04.008_bib241","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.2337\/dc20-0670","article-title":"A\u00a0pilot study of the feasibility and accuracy of inpatient continuous glucose monitoring","volume":"43","author":"Nair","year":"2020","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.eprac.2021.04.008_bib242","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.2337\/dc20-1016","article-title":"Glucose as the fifth vital sign: a randomized controlled trial of continuous glucose monitoring in a non-ICU hospital setting","volume":"43","author":"Fortmann","year":"2020","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.eprac.2021.04.008_bib243","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.2337\/dc20-1503","article-title":"Feasibility of inpatient continuous glucose monitoring during the COVID-19 pandemic: early experience","volume":"43","author":"Reutrakul","year":"2020","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.eprac.2021.04.008_bib246","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.2337\/dc20-0840","article-title":"Reducing inpatient hypoglycemia in the general wards using real-time continuous glucose monitoring: the glucose telemetry system, a randomized clinical trial","volume":"43","author":"Singh","year":"2020","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.eprac.2021.04.008_bib247","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jdiacomp.2018.05.005","article-title":"Detection of asymptomatic drug-induced hypoglycemia using continuous glucose monitoring in older people - systematic review","volume":"32","author":"Mattishent","year":"2018","journal-title":"J\u00a0Diabetes Complications"},{"issue":"4","key":"10.1016\/j.eprac.2021.04.008_bib248","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1177\/1932296816643542","article-title":"The impact of real-time continuous glucose monitoring in patients 65 years and older","volume":"10","author":"Polonsky","year":"2016","journal-title":"J\u00a0Diabetes Sci Technol"},{"issue":"6","key":"10.1016\/j.eprac.2021.04.008_bib249","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1177\/1932296817704445","article-title":"Continuous glucose monitoring in older adults with type 1 and type 2 diabetes using multiple daily injections of insulin: results from the DIAMOND trial","volume":"11","author":"Ruedy","year":"2017","journal-title":"J\u00a0Diabetes Sci Technol"},{"issue":"6","key":"10.1016\/j.eprac.2021.04.008_bib250","doi-asserted-by":"crossref","first-page":"365","DOI":"10.7326\/M16-2855","article-title":"Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: a randomized trial","volume":"167","author":"Beck","year":"2017","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.eprac.2021.04.008_bib251","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.2337\/dc12-2467","article-title":"Large pre- and postexercise rapid-acting insulin reductions preserve glycemia and prevent early- but not late-onset hypoglycemia in patients with type 1 diabetes","volume":"36","author":"Campbell","year":"2013","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.eprac.2021.04.008_bib252","first-page":"629","article-title":"Avoiding hypoglycemia: the use of insulin pump combined with continuous glucose monitor in type 1 diabetes crossing a Rocky Gorge","volume":"111","author":"Thomakos","year":"2018","journal-title":"Q\u00a0J M"},{"issue":"8","key":"10.1016\/j.eprac.2021.04.008_bib253","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/pedi.12509","article-title":"Outcomes of algorithm-based modifications of insulinotherapy during exercise in MDI vs insulin pump-treated children with type 1 diabetes: results from the TREAD-DIAB study","volume":"18","author":"Moniotte","year":"2017","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.eprac.2021.04.008_bib254","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.diabres.2015.11.012","article-title":"Accuracy of continuous glucose monitoring during differing exercise conditions","volume":"112","author":"Bally","year":"2016","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"10.1016\/j.eprac.2021.04.008_bib255","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/dme.13909","article-title":"Impact of physical exercise on sensor performance of the FreeStyle Libre intermittently viewed continuous glucose monitoring system in people with Type 1 diabetes: a randomized crossover trial","volume":"36","author":"Moser","year":"2019","journal-title":"Diabet Med"},{"issue":"6","key":"10.1016\/j.eprac.2021.04.008_bib256","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/dia.2018.0364","article-title":"Lag time remains with newer real-time continuous glucose monitoring technology during aerobic exercise in adults living with type 1 diabetes","volume":"21","author":"Zaharieva","year":"2019","journal-title":"Diabetes Technol Ther"},{"issue":"6","key":"10.1016\/j.eprac.2021.04.008_bib257","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1177\/1932296816645119","article-title":"Efficacy of an overnight predictive low-glucose suspend system in relation to hypoglycemia risk factors in youth and adults with type 1 diabetes","volume":"10","author":"Calhoun","year":"2016","journal-title":"J\u00a0Diabetes Sci Technol"},{"issue":"11","key":"10.1016\/j.eprac.2021.04.008_bib258","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1007\/s00125-017-4395-z","article-title":"Closed-loop glucose control in young people with type 1 diabetes during and after unannounced physical activity: a randomised controlled crossover trial","volume":"60","author":"Dovc","year":"2017","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.eprac.2021.04.008_bib259","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.2337\/dc18-0228","article-title":"Randomized outpatient trial of single- and dual-hormone closed-loop systems that adapt to exercise using wearable sensors","volume":"41","author":"Castle","year":"2018","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.eprac.2021.04.008_bib260","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/dom.12707","article-title":"Randomized trial of a dual-hormone artificial pancreas with dosing adjustment during exercise compared with no adjustment and sensor-augmented pump therapy","volume":"18","author":"Jacobs","year":"2016","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"10.1016\/j.eprac.2021.04.008_bib261","doi-asserted-by":"crossref","first-page":"838","DOI":"10.2337\/dc12-0816","article-title":"Closed-loop basal insulin delivery over 36 hours in adolescents with type 1 diabetes: randomized clinical trial","volume":"36","author":"Elleri","year":"2013","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.eprac.2021.04.008_bib262","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/dom.12552","article-title":"Insulin-based strategies to prevent hypoglycaemia during and after exercise in adult patients with type 1 diabetes on pump therapy: the DIABRASPORT randomized study","volume":"17","author":"Franc","year":"2015","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"10.1016\/j.eprac.2021.04.008_bib263","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1089\/dia.2011.0292","article-title":"Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study","volume":"14","author":"Garg","year":"2012","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"10.1016\/j.eprac.2021.04.008_bib264","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1089\/dia.2018.0279","article-title":"Glucose control using a standard versus an enhanced hybrid closed loop system: a randomized crossover study","volume":"21","author":"Paldus","year":"2019","journal-title":"Diabetes Technol Ther"},{"issue":"2","key":"10.1016\/j.eprac.2021.04.008_bib265","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/1357633X16631628","article-title":"A\u00a0randomised, controlled trial of the effects of a mobile telehealth intervention on clinical and patient-reported outcomes in people with poorly controlled diabetes","volume":"23","author":"Baron","year":"2017","journal-title":"J\u00a0Telemed Telecare"},{"key":"10.1016\/j.eprac.2021.04.008_bib266","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2337\/dc19-0739","article-title":"Randomized study to evaluate the impact of telemedicine care in patients with type 1 diabetes with multiple doses of insulin and suboptimal HbA(1c) in Andalusia (Spain): PLATEDIAN study","volume":"43","author":"Ruiz de Adana","year":"2020","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.eprac.2021.04.008_bib267","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00592-019-01300-1","article-title":"A\u00a0randomized controlled trial comparing a telemedicine therapeutic intervention with routine care in adults with type 1 diabetes mellitus treated by insulin pumps","volume":"56","author":"Yaron","year":"2019","journal-title":"Acta Diabetol"},{"issue":"4","key":"10.1016\/j.eprac.2021.04.008_bib268","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jand.2018.11.013","article-title":"Impact of ENHANCED (diEtitiaNs Helping pAtieNts CarE for Diabetes) telemedicine randomized controlled trial on diabetes optimal care outcomes in patients with type 2 diabetes","volume":"119","author":"Benson","year":"2019","journal-title":"J\u00a0Acad Nutr Diet"},{"issue":"5","key":"10.1016\/j.eprac.2021.04.008_bib269","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1177\/1932296819888662","article-title":"A virtual type 2 diabetes clinic using continuous glucose monitoring and endocrinology visits","volume":"14","author":"Dixon","year":"2020","journal-title":"J\u00a0Diabetes Sci Technol"},{"issue":"9","key":"10.1016\/j.eprac.2021.04.008_bib270","doi-asserted-by":"crossref","first-page":"E341","DOI":"10.1503\/cmaj.150885","article-title":"Effect of telemedicine on glycated hemoglobin in diabetes: a systematic review and meta-analysis of randomized trials","volume":"189","author":"Faruque","year":"2017","journal-title":"CMAJ"},{"issue":"7","key":"10.1016\/j.eprac.2021.04.008_bib271","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.2196\/jmir.4112","article-title":"Overcoming clinical inertia: a randomized clinical trial of a telehealth remote monitoring intervention using paired glucose testing in adults with type 2 diabetes","volume":"17","author":"Greenwood","year":"2015","journal-title":"J\u00a0Med Internet Res"},{"issue":"6","key":"10.1016\/j.eprac.2021.04.008_bib272","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s40618-018-0975-0","article-title":"Evaluating the effects of mobile health intervention on weight management, glycemic control and pregnancy outcomes in patients with gestational diabetes mellitus","volume":"42","author":"Guo","year":"2019","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"6","key":"10.1016\/j.eprac.2021.04.008_bib273","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1530\/EJE-16-0811","article-title":"Video consultations as add-on to standard care among patients with type 2 diabetes not responding to standard regimens: a randomized controlled trial","volume":"176","author":"Hansen","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.eprac.2021.04.008_bib274","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00592-015-0754-8","article-title":"Multifactorial intervention in diabetes care using real-time monitoring and tailored feedback in type 2 diabetes","volume":"53","author":"Lim","year":"2016","journal-title":"Acta Diabetol"},{"issue":"1","key":"10.1016\/j.eprac.2021.04.008_bib275","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s40200-019-00482-3","article-title":"Assessment of remote patient monitoring (RPM) systems for patients with type 2 diabetes: a systematic review and meta-analysis","volume":"19","author":"Salehi","year":"2020","journal-title":"J\u00a0Diabetes Metabolic Disord"},{"issue":"5","key":"10.1016\/j.eprac.2021.04.008_bib276","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/1357633X15598425","article-title":"Impact of long-term use of eHealth systems in adolescents with type 1 diabetes treated with sensor-augmented pump therapy","volume":"22","author":"Schiaffini","year":"2016","journal-title":"J\u00a0Telemed Telecare"},{"issue":"7","key":"10.1016\/j.eprac.2021.04.008_bib277","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1089\/tmj.2018.0128","article-title":"Clinical effectiveness of telemedicine in diabetes mellitus: a meta-analysis of 42 randomized controlled trials","volume":"25","author":"Tchero","year":"2019","journal-title":"Telemed J E Health"},{"issue":"9","key":"10.1016\/j.eprac.2021.04.008_bib278","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/imj.12515","article-title":"Effect of hospital-based telephone coaching on glycaemic control and adherence to management guidelines in type 2 diabetes, a randomised controlled trial","volume":"44","author":"Varney","year":"2014","journal-title":"Intern Med J"},{"issue":"1","key":"10.1016\/j.eprac.2021.04.008_bib279","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12902-019-0347-6","article-title":"Mobile health in the management of type 1 diabetes: a systematic review and meta-analysis","volume":"19","author":"Wang","year":"2019","journal-title":"BMC Endocr Disord"},{"issue":"4","key":"10.1016\/j.eprac.2021.04.008_bib280","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2337\/cd19-0105","article-title":"Impact of participation in a virtual diabetes clinic on diabetes-related distress in individuals with type 2 diabetes","volume":"38","author":"Polonsky","year":"2020","journal-title":"Clin Diabetes"},{"issue":"5","key":"10.1016\/j.eprac.2021.04.008_bib281","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1177\/1060028020950726","article-title":"Impact of telehealth interventions on medication adherence for patients with type 2 diabetes, hypertension, and\/or dyslipidemia: a systematic review","volume":"55","author":"Bingham","year":"2020","journal-title":"Ann Pharmacother"},{"issue":"5","key":"10.1016\/j.eprac.2021.04.008_bib282","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1089\/dia.2017.0450","article-title":"CoYoT1 clinic: home telemedicine increases young adult engagement in diabetes care","volume":"20","author":"Reid","year":"2018","journal-title":"Diabetes Technol Ther"},{"issue":"8","key":"10.1016\/j.eprac.2021.04.008_bib283","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1111\/pedi.13133","article-title":"Outcomes of monthly video consultations as an add-on to regular care for children with type 1 diabetes: a 6-month quasi-randomized clinical trial followed by an extension phase","volume":"21","author":"von Sengbusch","year":"2020","journal-title":"Pediatr Diabetes"},{"issue":"4","key":"10.1016\/j.eprac.2021.04.008_bib285","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1177\/1932296820932903","article-title":"Implementation of continuous glucose monitoring in the hospital: emergent considerations for remote glucose monitoring during the COVID-19 pandemic","volume":"14","author":"Galindo","year":"2020","journal-title":"J\u00a0Diabetes Sci Technol"},{"issue":"6","key":"10.1016\/j.eprac.2021.04.008_bib286","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1089\/dia.2020.0206","article-title":"Inpatient transition to virtual care during COVID-19 pandemic","volume":"22","author":"Jones","year":"2020","journal-title":"Diabetes Technol Ther"},{"issue":"23","key":"10.1016\/j.eprac.2021.04.008_bib287","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1056\/NEJMp2005835","article-title":"Covid-19 and health care's digital revolution","volume":"382","author":"Keesara","year":"2020","journal-title":"New Eng J Med"},{"issue":"6","key":"10.1016\/j.eprac.2021.04.008_bib288","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1089\/dia.2020.0187","article-title":"The silver lining to COVID-19: avoiding diabetic ketoacidosis admissions with telehealth","volume":"22","author":"Peters","year":"2020","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"10.1016\/j.eprac.2021.04.008_bib289","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2337\/dci19-0062","article-title":"Diabetes digital app technology: benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group","volume":"43","author":"Fleming","year":"2020","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.eprac.2021.04.008_bib290","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00125-019-05034-1","article-title":"Diabetes digital app technology: benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group","volume":"63","author":"Fleming","year":"2020","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.eprac.2021.04.008_bib291","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1177\/1932296817713506","article-title":"A\u00a0systematic review of reviews evaluating technology-enabled diabetes self-management education and support","volume":"11","author":"Greenwood","year":"2017","journal-title":"J\u00a0Diabetes Sci Technol"},{"issue":"3","key":"10.1016\/j.eprac.2021.04.008_bib292","doi-asserted-by":"crossref","first-page":"R93","DOI":"10.1530\/EJE-14-0441","article-title":"Management of endocrine disease. Effects of telecare intervention on glycemic control in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials","volume":"172","author":"Huang","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.eprac.2021.04.008_bib293","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1177\/1932296814529885","article-title":"Improving type 1 diabetes management with mobile tools: a systematic review","volume":"8","author":"Peterson","year":"2014","journal-title":"J\u00a0Diabetes Sci Technol"},{"issue":"1","key":"10.1016\/j.eprac.2021.04.008_bib294","doi-asserted-by":"crossref","DOI":"10.2196\/12297","article-title":"The efficacy of mobile phone apps for lifestyle modification in diabetes: systematic review and meta-analysis","volume":"7","author":"Wu","year":"2019","journal-title":"JMIR mHealth uHealth"},{"issue":"12","key":"10.1016\/j.eprac.2021.04.008_bib295","doi-asserted-by":"crossref","DOI":"10.2196\/15401","article-title":"Effectiveness of smartphone app-based interactive management on glycemic control in Chinese patients with poorly controlled diabetes: a randomized controlled trial","volume":"21","author":"Zhang","year":"2019","journal-title":"J\u00a0Med Internet Res"},{"issue":"3","key":"10.1016\/j.eprac.2021.04.008_bib296","first-page":"693","article-title":"Smartphones and apps to control glycosylated hemoglobin (HbA1c) level in diabetes: a systematic review and meta-analysis","volume":"9","author":"Martos-Cabrera","year":"2020","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.eprac.2021.04.008_bib297","series-title":"Technical Brief No. 31. (Prepared by the Scientific Resource Center under Contract Nos. 290- 2012-0004-C and 290-2017-00003-C.) AHRQ Publication No. 18-EHC010-EF. AHRQ Comparative Effectiveness Technical Briefs","author":"Veazie","year":"2018"},{"issue":"6","key":"10.1016\/j.eprac.2021.04.008_bib302","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1177\/1932296820954163","article-title":"Continuous glucose monitors and automated insulin dosing systems in the Hospital Consensus Guideline","volume":"14","author":"Galindo","year":"2020","journal-title":"J\u00a0Diabetes Sci Technol"},{"issue":"5","key":"10.1016\/j.eprac.2021.04.008_bib303","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1089\/dia.2018.0028","article-title":"Interference assessment of various endogenous and exogenous substances on the performance of the Eversense long-term implantable continuous glucose monitoring system","volume":"20","author":"Lorenz","year":"2018","journal-title":"Diabetes Technol Ther"},{"issue":"suppl 2","key":"10.1016\/j.eprac.2021.04.008_bib304","doi-asserted-by":"crossref","first-page":"S243","DOI":"10.1089\/dia.2015.0410","article-title":"Direct evidence of acetaminophen interference with subcutaneous glucose sensing in humans: a pilot study","volume":"18","author":"Basu","year":"2016","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.eprac.2021.04.008_bib306","author":"Hoskins"},{"issue":"2","key":"10.1016\/j.eprac.2021.04.008_bib307","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1089\/dia.2020.0234","article-title":"The effectiveness of virtual training on the MiniMed 670G system in people with type 1 diabetes during the COVID-19 pandemic","volume":"23","author":"Vigersky","year":"2021","journal-title":"Diabetes Technol Ther"},{"issue":"12","key":"10.1016\/j.eprac.2021.04.008_bib308","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.2337\/dc18-0917","article-title":"Efficacy of an education program for people with diabetes and Insulin Pump Treatment (INPUT): results from a randomized controlled trial","volume":"41","author":"Ehrmann","year":"2018","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.eprac.2021.04.008_bib309","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1055\/s-0032-1331708","article-title":"The effect of using the insulin pump bolus calculator compared to standard insulin dosage calculations in patients with type 1 diabetes mellitus - systematic review","volume":"121","author":"Ramotowska","year":"2013","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"2","key":"10.1016\/j.eprac.2021.04.008_bib310","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/dmrr.2477","article-title":"Bolus calculator and wirelessly communicated blood glucose measurement effectively reduce hypoglycaemia in type 1 diabetic children - randomized controlled trial","volume":"30","author":"Ramotowska","year":"2014","journal-title":"Diabetes Metab Res Rev"},{"issue":"6","key":"10.1016\/j.eprac.2021.04.008_bib311","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.clinthera.2018.02.004","article-title":"Effect of automated bolus calculation on glucose variability and quality of life in patients with type 1 diabetes on CSII treatment","volume":"40","author":"van Meijel","year":"2018","journal-title":"Clin Ther"},{"issue":"11","key":"10.1016\/j.eprac.2021.04.008_bib312","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.2337\/dc13-0251","article-title":"Use of an insulin bolus advisor improves glycemic control in multiple daily insulin injection (MDI) therapy patients with suboptimal glycemic control: first results from the ABACUS trial","volume":"36","author":"Ziegler","year":"2013","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.eprac.2021.04.008_bib314","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1089\/dia.2013.0192","article-title":"Nonmetabolic complications of continuous subcutaneous insulin infusion: a patient survey","volume":"16","author":"Pickup","year":"2014","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"10.1016\/j.eprac.2021.04.008_bib315","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/dmrr.2653","article-title":"Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics","volume":"32","author":"Pozzilli","year":"2016","journal-title":"Diabetes Metab Res Rev"},{"issue":"5","key":"10.1016\/j.eprac.2021.04.008_bib316","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/dme.13294","article-title":"Insulin pump failures in Italian children with type 1 diabetes: retrospective 1-year cohort study","volume":"34","author":"Rabbone","year":"2017","journal-title":"Diabet Med"},{"issue":"5","key":"10.1016\/j.eprac.2021.04.008_bib317","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1177\/193229681200600509","article-title":"Pediatric use of insulin pump technology: a retrospective study of adverse events in children ages 1-12 years","volume":"6","author":"Cope","year":"2012","journal-title":"J\u00a0Diabetes Sci Technol"},{"key":"10.1016\/j.eprac.2021.04.008_bib318","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00592-015-0784-2","article-title":"Clinical review: insulin pump-associated adverse events in adults and children","volume":"52","author":"Ross","year":"2015","journal-title":"Acta Diabetol"},{"issue":"2","key":"10.1016\/j.eprac.2021.04.008_bib320","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2020-001329","article-title":"Causes of diabetic ketoacidosis among adults with type 1 diabetes mellitus: insulin pump users and non-users","volume":"8","author":"Flores","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"5","key":"10.1016\/j.eprac.2021.04.008_bib322","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1089\/dia.2020.0535","article-title":"A real-world prospective study of the safety and effectiveness of the loop open source automated insulin delivery system","volume":"23","author":"Lum","year":"2021","journal-title":"Diabetes Technol Ther"},{"issue":"10","key":"10.1016\/j.eprac.2021.04.008_bib323","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/dme.12740","article-title":"Clinical outcomes of adult inpatients treated with continuous subcutaneous insulin infusion for diabetes mellitus: a systematic review","volume":"32","author":"Anstey","year":"2015","journal-title":"Diabet Med"},{"key":"10.1016\/j.eprac.2021.04.008_bib324","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s12020-016-1039-x","article-title":"Continuous subcutaneous insulin infusion versus multiple daily injections in individuals with type 1 diabetes: a systematic review and meta-analysis","volume":"55","author":"Benkhadra","year":"2017","journal-title":"Endocrine"},{"issue":"6","key":"10.1016\/j.eprac.2021.04.008_bib325","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S2213-8587(19)30150-0","article-title":"Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial","volume":"7","author":"Bosi","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"10.1016\/j.eprac.2021.04.008_bib326","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4103\/jfmpc.jfmpc_869_19","article-title":"Impact of insulin pump therapy on glycemic control among adult Saudi type-1 diabetic patients. An interview-based case-control study","volume":"9","author":"Almogbel","year":"2020","journal-title":"J\u00a0Family Med Prim Care"},{"issue":"14","key":"10.1016\/j.eprac.2021.04.008_bib327","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1001\/jama.2017.13994","article-title":"Association of insulin pump therapy vs insulin injection therapy with severe hypoglycemia, ketoacidosis, and glycemic control among children, adolescents, and young adults with type 1 diabetes","volume":"318","author":"Karges","year":"2017","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.eprac.2021.04.008_bib328","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1089\/dia.2018.0331","article-title":"Pediatric endocrinology trainees' education and knowledge about insulin pumps and continuous glucose monitors","volume":"21","author":"Marks","year":"2019","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"10.1016\/j.eprac.2021.04.008_bib329","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-000731","article-title":"Redesigning ambulatory care management for uncontrolled type 2 diabetes: a prospective cohort study of the impact of a Boot Camp model on outcomes","volume":"7","author":"Magee","year":"2019","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"4","key":"10.1016\/j.eprac.2021.04.008_bib330","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1177\/0145721720935123","article-title":"Technology integration: the role of the diabetes care and education specialist in practice","volume":"46","author":"Isaacs","year":"2020","journal-title":"Diabetes Educ"},{"issue":"1","key":"10.1016\/j.eprac.2021.04.008_bib332","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12902-020-0518-5","article-title":"Hypoglycemia in patients with type 2 diabetes treated with oral antihyperglycemic agents detected by continuous glucose monitoring: a multi-center prospective observational study in Croatia","volume":"20","author":"Bareti\u0107","year":"2020","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.eprac.2021.04.008_bib333","doi-asserted-by":"crossref","DOI":"10.1089\/dia.2018.0115","article-title":"Emerging technologies for diabetes care","author":"Bailey","year":"2018","journal-title":"Diabetes Technol Ther"},{"issue":"8","key":"10.1016\/j.eprac.2021.04.008_bib334","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1080\/17434440.2018.1503530","article-title":"Closed-loop insulin delivery: current status of diabetes technologies and future prospects","volume":"15","author":"Majeed","year":"2018","journal-title":"Expert Rev Med Devices"},{"issue":"3","key":"10.1016\/j.eprac.2021.04.008_bib335","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1177\/1932296816688010","article-title":"Optimal use of diabetes devices: clinician perspectives on barriers and adherence to device use","volume":"11","author":"Tanenbaum","year":"2017","journal-title":"J\u00a0Diabetes Sci Technol"},{"issue":"2","key":"10.1016\/j.eprac.2021.04.008_bib336","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s13142-016-0418-4","article-title":"Use of self-monitoring tools in a clinic sample of adults with type 2 diabetes","volume":"7","author":"Tanenbaum","year":"2017","journal-title":"Transl Behav Med"},{"issue":"1","key":"10.1016\/j.eprac.2021.04.008_bib337","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12902-018-0239-1","article-title":"Patients' and caregivers' experiences of using continuous glucose monitoring to support diabetes self-management: qualitative study","volume":"18","author":"Lawton","year":"2018","journal-title":"BMC Endocr Disord"},{"issue":"12","key":"10.1016\/j.eprac.2021.04.008_bib338","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1007\/s00125-018-4729-5","article-title":"Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"61","author":"Davies","year":"2018","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.eprac.2021.04.008_bib339","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1464-5491.2011.03466.x","article-title":"Poor numeracy skills are associated with glycaemic control in Type 1 diabetes","volume":"29","author":"Marden","year":"2012","journal-title":"Diabet Med"},{"issue":"4","key":"10.1016\/j.eprac.2021.04.008_bib340","doi-asserted-by":"crossref","first-page":"152","DOI":"10.2337\/diaclin.32.4.152","article-title":"Diabetes numeracy and blood glucose control: association with type of diabetes and source of care","volume":"32","author":"Zaugg","year":"2014","journal-title":"Clin Diabetes"},{"issue":"2","key":"10.1016\/j.eprac.2021.04.008_bib341","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1177\/193229681200600218","article-title":"Performance of a glucose meter with a built-in automated bolus calculator versus manual bolus calculation in insulin-using subjects","volume":"6","author":"Sussman","year":"2012","journal-title":"J\u00a0Diabetes Sci Technol"},{"issue":"3","key":"10.1016\/j.eprac.2021.04.008_bib342","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1089\/dia.2015.0240","article-title":"Evaluation of the adherence to continuous glucose monitoring in the management of type 1 diabetes patients on sensor-augmented pump therapy: the SENLOCOR study","volume":"18","author":"Picard","year":"2016","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.eprac.2021.04.008_bib343","first-page":"E109","article-title":"Lasting effects of a 2-year diabetes self-management support intervention: outcomes at 1-year follow-up","volume":"9","author":"Tang","year":"2012","journal-title":"Prev Chronic Dis"},{"issue":"1","key":"10.1016\/j.eprac.2021.04.008_bib344","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.diabres.2011.04.003","article-title":"Sustaining short-term improvements over the long-term: results from a 2-year diabetes self-management support (DSMS) intervention","volume":"95","author":"Tang","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"issue":"7","key":"10.1016\/j.eprac.2021.04.008_bib345","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/pedi.12888","article-title":"A\u00a0person-centered education for adolescents with type 1 diabetes-A randomized controlled trial","volume":"20","author":"Brorsson","year":"2019","journal-title":"Pediatr Diabetes"},{"issue":"12","key":"10.1016\/j.eprac.2021.04.008_bib346","doi-asserted-by":"crossref","first-page":"e266","DOI":"10.2196\/jmir.2699","article-title":"Evaluating self-management behaviors of diabetic patients in a telehealthcare program: longitudinal study over 18 months","volume":"15","author":"Chen","year":"2013","journal-title":"J\u00a0Med Internet Res"},{"issue":"2","key":"10.1016\/j.eprac.2021.04.008_bib347","doi-asserted-by":"crossref","first-page":"344","DOI":"10.2478\/ams-2013-0024","article-title":"Monthly use of a real-time continuous glucose monitoring system as an educational and motivational tool for poorly controlled type 1 diabetes adolescents","volume":"58","author":"G\u0142owi\u0144ska-Olszewska","year":"2013","journal-title":"Adv Med Sci"},{"issue":"12","key":"10.1016\/j.eprac.2021.04.008_bib348","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1016\/j.pec.2019.06.014","article-title":"Improving empowerment, motivation, and medical adherence in patients with poorly controlled type 2 diabetes: A randomized controlled trial of a patient-centered intervention","volume":"102","author":"Varming","year":"2019","journal-title":"Patient Educ Couns"},{"issue":"4","key":"10.1016\/j.eprac.2021.04.008_bib349","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1177\/1932296816681323","article-title":"The impact of structured self-monitoring of blood glucose combined with intensive education on HbA1c levels, hospitalizations, and quality-of-life parameters in insulin-treated patients with diabetes at primary care in Serbia: the multicenter SPA-EDU study","volume":"11","author":"Lali\u0107","year":"2017","journal-title":"J\u00a0Diabetes Sci Technol"},{"key":"10.1016\/j.eprac.2021.04.008_bib350","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.diabres.2019.03.003","article-title":"The impact of a structured education and treatment programme (FLASH) for people with diabetes using a flash sensor-based glucose monitoring system: Results of a randomized controlled trial","volume":"150","author":"Hermanns","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"10.1016\/j.eprac.2021.04.008_bib351","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00592-017-1070-2","article-title":"Substantial improvement in HbA1c following a treatment and teaching programme for people with type 2 diabetes on conventional insulin therapy in an in- and outpatient setting","volume":"55","author":"Kuniss","year":"2018","journal-title":"Acta Diabetol"},{"issue":"2","key":"10.1016\/j.eprac.2021.04.008_bib352","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1177\/193229681200600214","article-title":"Mobile phone-based video messages for diabetes self-care support","volume":"6","author":"Bell","year":"2012","journal-title":"J\u00a0Diabetes Sci Technol"},{"issue":"5","key":"10.1016\/j.eprac.2021.04.008_bib353","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1177\/0145721713492570","article-title":"Who can provide diabetes self-management support in primary care? Findings from a randomized controlled trial","volume":"39","author":"Siminerio","year":"2013","journal-title":"Diabetes Educ"},{"issue":"1","key":"10.1016\/j.eprac.2021.04.008_bib354","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/pedi.12518","article-title":"Schooling diabetes: use of continuous glucose monitoring and remote monitors in the home and school settings","volume":"19","author":"Erie","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.eprac.2021.04.008_bib355","doi-asserted-by":"crossref","unstructured":"Forlenza GP, Buckingham BA, Brown SA, et\u00a0al. First outpatient evaluation of a tubeless automated insulin delivery system with customizable glucose targets in children and adults with type 1 diabetes. Diabetes Technol Ther. 2021. https:\/\/doi.org\/10.1089\/dia.2020.0546. Epub ahead of print. [EL 2; PCS]","DOI":"10.1089\/dia.2020.0546"},{"key":"10.1016\/j.eprac.2021.04.008_bib356","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/dc21-0172","article-title":"Multicenter trial of a tubeless, on-body automated insulin delivery system with customizable glycemic targets in pediatric and adult participants with type 1 diabetes","volume":"44","author":"Brown","year":"2021","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.eprac.2021.04.008_bib357","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1038\/s41591-020-1045-7","article-title":"Insulin dose optimization using an automated artificial intelligence-based decision support system in youths with type 1 diabetes","volume":"26","author":"Nimri","year":"2020","journal-title":"Nat Med"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X21001658?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X21001658?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:10:01Z","timestamp":1761516601000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X21001658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":342,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S1530891X21001658"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2021.04.008","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2021.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc. on behalf of the AACE.","name":"copyright","label":"Copyright"}]}}